Skip to main content
SpringerLink
Log in

Fatty liver: Biochemical and clinical considerations

  • Progress Report
  • Published:
The American Journal of Digestive Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Isselbacher KJ, Alpers DH: Fatty liver, Biochemical and clinical aspects. Diseases of the Liver, 3rd edition. L Schiff (ed.). Philadelphia, Lippincott, 1969, pp 672–688

    Google Scholar 

  2. Masoro EJ: Physiological Chemistry of Lipids in Mammals. Physiological Chemistry Series. Philadelphia, WB Saunders, 1968

    Google Scholar 

  3. Margolis S, Capuzzi D: Serum-Lipoprotein Synthesis and Metabolism in Blood Lipids and Lipoproteins: Quantitations, Composition and Metabolism. GJ Nelson (ed). New York, Wiley-Interscience, 1972

    Google Scholar 

  4. Lombardi B: Considerations on the pathogenesis of fatty liver. Lab Invest 15:1–20, 1966

    Google Scholar 

  5. Recknagel RO: Carbon tetrachloride hepatotoxicity. Pharmacol Rev 19:145–208, 1967

    Google Scholar 

  6. White A, Handler P, Smith EL: Principles of Biochemistry, 4th edition, New York, McGraw-Hill, 1968

    Google Scholar 

  7. Mayes P: Metabolism of Lipids in Physiological Chemistry. HA Harper (ed). Los Altos, California, Lange Medical Publications, 1971

    Google Scholar 

  8. Stein O, Bar-on H, Stein Y: Lipoprotein and the liver. Progress in Liver Disease, Vol IV. H Popper and F. Schaffner (eds). New York and London, Grune and Stratton, 1972, pp 45–65

    Google Scholar 

  9. Robinson DS, French JE: Heparin, the clearing factor lipase, and fat transport. Pharmacol Rev 12:241–263, 1960

    Google Scholar 

  10. Raben MS: Regulation of fatty acid release with particular reference to pituitary factors. Adipose Tissue, Handbook of Physiology, Vol 5, (Am Physiol Soc, Washington, D.C.). Baltimore, Williams and Wilkins, 1965, pp 331–334

    Google Scholar 

  11. Carlson LA, Balty PR: Inhibition of lipid mobilization. Adipose Tissue, Handbook of Physiology, Vol 5 (Am Physiol Soc, Washington, D.C.). Baltimore, Williams and Wilkins, 1965, pp 557–574

    Google Scholar 

  12. Ockner RK, Manning JA, Poppenhauser RB, Ho WKL: A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium and other tissues. Science 177:56–58, 1972

    Google Scholar 

  13. Farber E: On the pathogenesis of fatty liver. Gastroenterology 50:137–141, 1966

    Google Scholar 

  14. Roheim PS, Miller L, Eder HA: The formation of plasma lipoproteins from apoprotein in plasma. J Biol Chem 240:2994–3001, 1965

    Google Scholar 

  15. Hamilton RL, Kaydes HJ: The liver and the formation of normal and abnormal plasma lipoprotein. Biochemistry of Disease, Vol 5, The Liver: Normal and Abnormal Function, Part A. FF Becker (ed). New York, Marcel Dekker, 1974, pp 531–588

    Google Scholar 

  16. Leevy CM, Zinke MR, White TJ, Guessi AM: Clinical observations on the fatty liver. Arch Intern Med 92:527–541, 1953

    Google Scholar 

  17. Leevy CM: Fatty liver: A study of 270 patients with biopsy-proven fatty liver and a review of the literature. Medicine 41:249, 1962

    Google Scholar 

  18. Holzbach RT, Wieland RG, Leiber CS, DeCarli LM, Koepke KR, Green SG: Hepatic lipid in morbid obesity. Assessment at end subsequent to jejunoileal bypass. N Engl J Med 290:296–299, 1974

    Google Scholar 

  19. Rubin E, Lieber CS: Alcohol-induced hepatic injury in non-alcoholic volunteers. N Engl J Med 278:869–876, 1968

    Google Scholar 

  20. Lieber CS: Effects of ethanol upon lipid metabolism. Lipids 9:103–116, 1974

    Google Scholar 

  21. Lieber CS, Spritz N, DeCarli LM: Role of dietary, adipose and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver. J Clin Invest 45:51–62, 1966

    Google Scholar 

  22. Bradus S, Korn RJ, Chomet B, West M, Zimmerman HJ: Hepatic function and serum enzyme levels in association with fatty metamorphosis of the liver. Am J Med Sci 246: 69–75, 1963

    Google Scholar 

  23. Iverson K, Christoffersen P, Paulsen H: Epitheloid cell granulomas in liver biopsies. Scand J Gastroenterol (Suppl) 7:61–67, 1970

    Google Scholar 

  24. Christoffersen P, Braendstrup O, Juhl E, Paulsen H: Lipogranulomas in human liver biopsies with fatty change. Acta Pathol Microbiol Scand, Sec A 19:150–158, 1971

    Google Scholar 

  25. Rubin E: The spectrum of alcoholic liver injury. The Liver, EA Gall (ed), Baltimore, Williams and Wilkins, 1973, pp 199–217

    Google Scholar 

  26. Middleton HM, Dunn GD, Schenker S: Alcohol-induced liver injury: pathogenetic considerations. The Liver—Normal and Abnormal Function, Part B. FF Becher (ed), Rye, New York, Marcel Dekker, 1974, pp 647–677

    Google Scholar 

  27. Gordon ER: Mitochondrial function in an ethanol-induced fatty liver. J Biol Chem 248:8271–8280, 1973

    Google Scholar 

  28. Lieber CS, Rubin E: Alcoholic fatty liver in man on high protein and low fat diet. Am J Med 44:200–206, 1968

    Google Scholar 

  29. Mezey E, Potter JJ, Maddrey WC: Hepatic collegen turnover in alcoholic liver disease. Gastroenterology 67:815, 1974

    Google Scholar 

  30. Chen TSN, Leevy CM: Collegen biosynthesis in liver disease of the alcoholic. J Lab Clin Med 85:103–112, 1975

    Google Scholar 

  31. Feinman G, Lieber CS: Hepatic collegen metabolism: Effect of alcohol consumption in rats and baboons. Science 176:795, 1972

    Google Scholar 

  32. Kramer K, Kullen L, Fisher R: The increasing mortality attributed to cirrhosis and fatty liver in Baltimore (1957–1966). Ann Intern Med 69:273–282, 1968

    Google Scholar 

  33. Trowell HC, Davies JNP, Dean RFA: Kwashiorkor. London, Edward Arnold, 1954

    Google Scholar 

  34. Coward WA, Whitehead RG, Coward DGL: Quantitative changes in serum protein fractions during the development of kwashiorkor and in recovery. Br J Nutr 28:433–441, 1972

    Google Scholar 

  35. Zaklama MS, Gabr MK, Maraghy SE, Patwardhan VN: Serum vitamin A in protein-calorie malnutrition. Am J Clin Nutr 26:1202–1206, 1973

    Google Scholar 

  36. Shiner M, Redmond AOB, Hansen JDL: The jejunal mucosa in protein-energy malnutrition. A clinical, histological and ultrastructural study. Exp Mol Pathol 19:61–78, 1973

    Google Scholar 

  37. Redmond AOB, Hansen JDL, McHutchon B: Abnormal bile salt metabolism in kwashiorkor. S Afr Med J 46:617–618, 1972

    Google Scholar 

  38. Kinnear AA, Pretorius PJ: Liver function in kwashiorkor. Br Med J 1:1528–1530, 1956

    Google Scholar 

  39. Webber BL, Freiman I: The liver in kwashiorkor. Arch Pathol 98:400–408, 1974

    Google Scholar 

  40. Wharton BA, McChesney EW: Chloroquine metabolism in kwashiorkor. J Trop Pediatr 16:130–132, 1970

    Google Scholar 

  41. Fletcher K: Observations on the origin of liver fat in infantile malnutrition. Am J Clin Nutr 19:170–174, 1966

    Google Scholar 

  42. Suckling PV, Campbell JAH: A five year follow-up of colored children with kwashiorkor in Cape Town. J Trop Pediatr 2:173–180, 1957

    Google Scholar 

  43. Cook GC, Hutt MSR: The liver after kwashiorkor. Br Med J 3:454–457, 1967

    Google Scholar 

  44. McLaren DS, Faris R, Zekian B: The liver during recovery from protein-calorie malnutrition. J Trop Med Hyg 71:271–281, 1968

    Google Scholar 

  45. Davies JNP: The essential pathology of kwashiorkor. Lancet 1:317–320, 1948

    Google Scholar 

  46. Ramalingaswami V: Perspectives in protein malnutrition. Nature 201:546–551, 1964

    Google Scholar 

  47. Theron JJ, Liebenberg N: Some observations on the fine cytology of the parenchymal liver cells in kwashiorkor patients. J Pathol Bacteriol 86:109–112, 1963

    Google Scholar 

  48. Ordy JM, Samorajski T, Zimmerman RR, Rady PM: Effects of postnatal protein deficiency on weight gain, serum proteins, enzymes, cholesterol and liver ultrastructure in subhuman primate (macaca mulatta). Am J Pathol 48:769–791, 1966

    Google Scholar 

  49. Lewis B, Hansen JDL, Witman W, Krut LH, Stewart F: Plasma free fatty acids in kwashiorkor and the pathogenesis of the fatty liver. Am J Clin Nutr 15:161–168, 1964

    Google Scholar 

  50. McDonald I: Liver and depot lipids in children on normal and high carbohydrate diets. Am J Clin Nutr 12:431–436, 1963

    Google Scholar 

  51. McDonald I, Hansen JDL, Bronte-Stewart B: Liver, depot and serum lipids during early recovery from kwashiorkor. Clin Sci 24:55–61, 1963

    Google Scholar 

  52. Flores H, Seakins A, Brooke OG, Waterlow JC: Serum and liver triglycerides in malnourished Jamaican children with fatty liver. Am J Clin Nutr 27:610–614, 1974

    Google Scholar 

  53. Rao KSJ, Prasad PSK: Serum triglycerides and nonesterified fatty acids in kwashiorkor. Am J Clin Nutr 19:205–209, 1966

    Google Scholar 

  54. Gilman J, Gilman T, Scragg J, Savage N, Gilbert C, Trant G, Leevy P: Some aspects of the metabolism of kwashiorkor and of normal infants as determined by the utilization of I-14C sodium acetate, 2-14C pyruvate and uniformlylabelled14C glucose. S Afr J Med Sci 26:31–61, 1961

    Google Scholar 

  55. Truswell AS, Hansen JDL, Watson CE, Wannenburg P: Relation of serum lipids and lipoproteins to fatty liver in kwashiorkor. Am J Clin Nutr 22:568–576, 1969

    Google Scholar 

  56. Kumar V, Dio MG, Ramalingaswami V: Mechanism of fatty liver in protein deficiency. An experimental study in rhesus monkey. Gastroenterology 62:445–451, 1972

    Google Scholar 

  57. Chaudhuri AD, Bhattacharyya AK, Mukherjie AM: The liver in pre-kwashiorkor and kwashiorkor-marasmus syndromes. Trans R Soc Trop Med Hyg 66:258–262, 1972

    Google Scholar 

  58. Graham GG: Disorders of nutritional homeostasis, Chapter 3. Pediatrics, 15th edition. HL Barnett and AH Einhorn (eds). New York, Appleton-Century-Crofts, 1972, pp 170–195

    Google Scholar 

  59. Salmon PA: The results of small intestine bypass operations for the treatment of obesity. Surg Gynecol Obstet 132:965–979, 1971

    Google Scholar 

  60. Scott HW, Dean R, Shull HJ, Abram HS, Webb W, Younger RK, Brill AB: New considerations in use of jejunoileal bypass in patients with marked obesity. Ann Surg 177:723–735, 1973

    Google Scholar 

  61. Kern WH, Heger AH, Payne JH, DeWind LT: Fatty metamorphosis of the liver in morbid obesity. Arch Pathol 96:342–346, 1973

    Google Scholar 

  62. Manes JL, Taylor HB, Starkloff GB: Relationship between hepatic morphology and clinical and biochemical findings in morbidly obese patients. J Clin Pathol 26:776–783, 1973

    Google Scholar 

  63. Berkowitz D: Metabolic changes associated with obesity before and after weight reduction. JAMA 187:399–403, 1964

    Google Scholar 

  64. Laurell S, Lundquist A: Lipid composition of human liver biopsy specimens. Acta Med Scand 189:65–68, 1971

    Google Scholar 

  65. Rosenthal P, Biavi C, Spender H, Zimmerman HJ: Liver morphology and function tests in obesity and during total starvation. Am J Dig Dis 12:198–208, 1967

    Google Scholar 

  66. Hilden M, Juhl E, Thomsen AC, Christoffersen. Fatty liver persisting for up to 33 years. A follow-up of the Iversen-Roholm liver biopsy material. Acta Med Scand 194:485–489, 1973

    Google Scholar 

  67. Massarat S, Jordan G, Sahrhage G, Korb G, Bode GC, Dolle W: Five-year follow-up study of patients with nonalcoholic and non-diabetic fatty liver. Acta Hepato-Gastroenterol 21:176–186, 1974

    Google Scholar 

  68. Scott HW, Sandstead HH, Brill AB, Burko H, Younger RK: Experience with a new technique of intestinal bypass in the treatment of morbid obesity. Ann Surg 174:560–572, 1971

    Google Scholar 

  69. Owen RL: Adaptations of intestinal structure following jejunoileal bypass for massive obesity. Gastroenterology 68:1083, 1975

    Google Scholar 

  70. Moxley RT, Posefsky T, Lockwood DH: Protein nutrition and liver disease after jejunoileal bypass for morbid obesity. N Engl J Med 290:921–926, 1974

    Google Scholar 

  71. Dowling RH, Booth CC: Functional compensation after small bowel resection in man: Demonstration by direct measurement. Lancet 2:146–147, 1966

    Google Scholar 

  72. Winawer SJ, Broitman SA, Wolochow DA et al: Successful management of massive small bowel resection based on assessment of absorption defects and nutritional needs. N Engl J Med 274:72–78, 1966

    Google Scholar 

  73. Schwartz MK, Medwid A, Roberts RE et al: Fat and nitrogen metabolism in patients with massive small bowel resections. Surg Forum 6:385–390, 1955

    Google Scholar 

  74. Brown RG, O'Leary JP, Woodward ER: Hepatic effects of jejunoileal bypass for morbid obesity. Am J Surg 127:53–58, 1974

    Google Scholar 

  75. Peters RL, Gay T, Reynolds TB: Post-jejunal-bypass hepatic disease. Its similarity to alcoholic liver disease. Amer J Clin Path 63:318–331, 1975

    Google Scholar 

  76. McGill DB, Humpherys SR, Baggenstoss AH, Dickson ER: Cirrhosis and death after jejunoileal shunt. gastroenterology 63:872–877, 1972

    Google Scholar 

  77. Mangla JC, Hoy W, Kim Y, Chopek M: Cirrhosis and death after jejunoileal shunt for obesity. Am J Dig Dis 19:759–765, 1974

    Google Scholar 

  78. Drenick EJ, Simmons F, Murphy JF: Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass. N Engl J Med 282:829–834, 1970

    Google Scholar 

  79. Dano P, Lenz K: Change of bile acid metabolism and absorption of vitamin B12 after intestinal shunt operation in obesity. A comparison of three types of operation. Scand J Gastroenterol 9:159–165, 1974

    Google Scholar 

  80. Wise L, Stein T: Cholic and chenodeoxycholic acid metabolism in massively obese patients before and after small bowel bypass. Gastroenterology 68:1014, 1975

    Google Scholar 

  81. Faloon WW, Rubulis A, Flood MS: Lithogenic and hepatotoxic potential in intestinal bypass. Gastroenterology 68:1073, 1975

    Google Scholar 

  82. Sherr HP, Nair PP, White JJ, Banwell JG, Lockwood DH: Bile acid metabolism and hepatic disease following small bowel bypass for obesity. Am J Clin Nutr 27:1369–1379, 1974

    Google Scholar 

  83. O'Leary JP, Maher JW, Hollenbeck JF, Woodward ER: Pathogenesis of hepatic failure following jejunoileal bypass. Gastroenterology 66:859, 1974

    Google Scholar 

  84. Creutzfeldt W, Frericks H, Sickinger K: Liver disease and diabetes mellitus. Progress in Liver Diseases, Vol 3. H Popper and F Schaffner (eds). Grune and Stratton, New York, pp 371–407

  85. Reinberg MH, Lipson M: The association of Laennec's cirrhosis with diabetes mellitus. Ann Intern Med 33:1195–1202, 1950

    Google Scholar 

  86. Wasastjerna C, Reissell P, Karjalainen J, Ekelund P: Fatty liver in diabetes. A cytological study. Acta Med Scand 191:225–228, 1972

    Google Scholar 

  87. Leevy CM, Ryan CM, Fineberg JC: Diabetes mellitus and liver dysfunction. Am J Med 8:290–299, 1950

    Google Scholar 

  88. Camarini-Davalos R, Marble A, Muench H: Liver function in diabetes mellitus. N Engl J Med 266:1349–1354, 1962

    Google Scholar 

  89. Hano T: Pathohistological study on the liver cirrhosis in diabetes mellitus. Kobe J Med Sci 14:87–106, 1968

    Google Scholar 

  90. Taylor PH, Wallace JC, Keech DB: Gluconeogenic enzymes in sheep liver. Intracellular localization of pyruvate carboxylase and phosphoenolpyruvate carboxykinase in normal, fasted and diabetic sheep. Biochem Biophys Acta 237:79–91, 1971

    Google Scholar 

  91. Harano Y, DePalma RG, Lavine L, Miller M: Fatty acid oxidation, oxidative phosphorylation and ultrastructure of mitochondria in the diabetic rat liver. Diabetes 21:257–270, 1972

    Google Scholar 

  92. Pilkis SJ, Korner A: Effect of diabetes and insulin treatment on protein synthetic activity of rat liver ribosomes. Biochem Biophys Acta 247:597–608, 1971

    Google Scholar 

  93. Reaves EP, Peterson DT, Reaves GM: The effect of experimental diabetes mellitus and insulin replacement on hepatic ultrastructure and protein synthesis. J Clin Invest 52:248–262, 1973

    Google Scholar 

  94. Wepler W, Wildhirt E: Clinical Histopathology of the Liver (translated by Leo Lowbeer). New York, Grune and Stratton, 1972, pp 83–87

    Google Scholar 

  95. Bierman EL, Dole VP, Roberts TN: An abnormality of non-esterified fatty acid metabolism in diabetes mellitus. Diabetes 6:475–479, 1957

    Google Scholar 

  96. Heimberg M, van Harken DR, Brown TO: Hepatic lipid metabolism in experimental diabetes. Biochem Biophys Acta 137:435–445, 1967

    Google Scholar 

  97. Bagdade JD, Porte, Jr. D, Bierman EL: Diabetic lipemia. A form of acquired fat-induced lipemia. N Engl J Med 276:427–433, 1967

    Google Scholar 

  98. Kreisberg RA, Boshell BR, Diplacido J, Roddam RF: Insulin secretion in obesity. N Engl J Med 276:314–319, 1967

    Google Scholar 

  99. Perley M, Kipnis DM: Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and non-diabetic subjects. Diabetes 15:867–874, 1966

    Google Scholar 

  100. Warren S, LeCompte PM, Legg MA: The Pathology of Diabetes Mellitus, 4th edition. Philadelphia, Lea and Febiger, 1966, pp 299–300

    Google Scholar 

  101. Sheehan HL: The pathology of acute yellow atrophy and delayed chloroform poisoning. J Obstet Br Emp 47:49–62, 1940

    Google Scholar 

  102. Stander HJ, Cadden JF: Acute yellow atrophy of the liver in pregnancy. Am J Obstet Gynecol 28:61–69, 1934

    Google Scholar 

  103. Cullinan ER: Idiopathic jaundice (often recurrent) associated with subacute necrosis of the liver. St. Bart Hosp Rep 69:55–142, 1936

    Google Scholar 

  104. Whitacre FF, Fang LY: Fatty degeneration of the liver in pregnancy. Report of a case with recovery: Chemical and histologic studies. JAMA 118:1358–1364, 1942

    Google Scholar 

  105. Nixon WCW, Egeli ES, Laqueur W, Yahya O: Icterus in pregnancy. A clinicopathological study including liver biopsy. J Obstet Gynecol Br Emp 54:642–652, 1947

    Google Scholar 

  106. Ober WO, Lecompte PM: Acute fatty metamorphosis of the liver associated with pregnancy. A distinctive lesion. Am J Med 19:743–758, 1955

    Google Scholar 

  107. Barry AP, O'Dwyer E: Hepatitis in pregnancy. Irish J Med Sci 6:419–424, 1955

    Google Scholar 

  108. Moore HC: Acute fatty liver of pregnancy. Irish J Med Sci 7:451–458, 1955

    Google Scholar 

  109. Moore HC: Acute fatty liver of pregnancy. J Obstet Gynecol Br Emp 63:189–198, 1956

    Google Scholar 

  110. Mason DG: Acute fatty metamorphosis of the liver associated with pregnancy (CPC). Northwest Med 57:456–462, 1958

    Google Scholar 

  111. Lynch MJ, Kyle PR, Raphael SS, Bruce-Lockhart P: Unusual ovarian changes (hyperthecosis) in pregnancy. Am J Obstet Gynecol 77:335–347, 1959

    Google Scholar 

  112. Dyson BC: Fatty metamorphosis of the liver in pregnancy: Report of a fatal case without jaundice. Bull Ayer Clin Lab Penn Hosp 4:17–30, 1959

    Google Scholar 

  113. Nardone AA, Stroup PE, Gill RJ: Acute fatty metamorphosis of the liver in pregnancy. Report of a case complicating toxemia in pregnancy. Am J Obstet Gynecol 80:258–262, 1960

    Google Scholar 

  114. Bruno MS, Ober WB: Jaundice at the end of pregnancy. Clinicopathological conference. NY State J Med 62:3792–3800, 1962

    Google Scholar 

  115. Recant L, Lacy P (eds): Clinico-pathological conference. Fulminating liver disease in a pregnant woman at term. Am J Med 35:231–240, 1963

    Google Scholar 

  116. Siegler AM, Keyser H: Acute hepatitis in pregnancy. A report of ten cases and review to the literature. Am J Obstet Gynecol 86:1068–1073, 1963

    Google Scholar 

  117. Barker J, Dunn RB: Obstetric acute yellow atrophy of the liver. Report of a case. Obstet Gynecol 24:626–628, 1964

    Google Scholar 

  118. Kahil ME, Fred HL, Brown H, Davis JS: Acute fatty liver of pregnancy. Report of two cases. Arch Intern Med 113:63–69, 1964

    Google Scholar 

  119. Woolf AJ, Johnston AW, Stokes JF, Roberton NRC: Acute liver failure in pregnancy. Case report with survival of mother and child. J Obstet Gynaecol Br Commonw 71:914–918, 1964

    Google Scholar 

  120. Douvres PA, Rosenthal WS, Metzger P, Tchertoff V: Acute fatty liver of pregnancy with hepatic coma and Mallory-Weiss syndrome: Report of a case. Am J Dig Dis 10:306–313, 1965

    Google Scholar 

  121. Kunelis CT, Peters RL, Edmondson HA: Fatty liver of pregnancy and its relationship to tetracycline therapy. Am J Med 38:359–377, 1965

    Google Scholar 

  122. Duma RJ, Dowling EA, Alexander HC, Sibraus D, Dempsey H: Acute fatty liver of pregnancy. Report of a surviving patient studied with serial liver biopsies. Ann Intern Med 63:851–858, 1965

    Google Scholar 

  123. Schiffer MA: Fatty liver associated with administration of tetracycline in pregnant and non-pregnant women. Am J Obstet Gynecol 96:326–332, 1966

    Google Scholar 

  124. Berger RL, Stanton JR, Liversage RM, McGoldrick DM, Graham JH, Stohlman F: Blood exchange in the treatment of hepatic coma. JAMA 202:267–274, 1967

    Google Scholar 

  125. Joske RA, McCully DS, Mastaglia FL: Acute fatty liver of pregnancy. Gut 9:389–493, 1968

    Google Scholar 

  126. Breen KJ, Perkins KW, Mistilis SP, Shearman R: Idiopathic acute fatty liver of pregnancy. Gut 11:822–825, 1970

    Google Scholar 

  127. Wood EE: A case of acute fatty liver of pregnancy. J Obstet Gynecol 77:377–342, 1970

    Google Scholar 

  128. Nash DT, Tomasziwics J: Acute yellow atrophy of liver in pregnancy. NY State J Med 71:458–465, 1971

    Google Scholar 

  129. Breen KJ, Perkins KW, Schenker S, Dunkerley RC, Moore HC: Uncomplicated subsequent pregnancy after idiopathic fatty liver of pregnancy. Obstet Gynecol 40:813–815, 1972

    Google Scholar 

  130. Hatfield AK, Stein JA, Greenberger NJ, Abernathy RW, Ferris TF: Idiopathic acute fatty liver of pregnancy. Death from extrahepatic manifestations. Am J Dig Dis 17:167–178, 1972

    Google Scholar 

  131. Holzback RT: Acute fatty liver of pregnancy with disseminated intravascular coagulation. Obstet Gynecol 43:740–744, 1974

    Google Scholar 

  132. Cano RI, Delman MR, Pitchmorie CS, Lev R, Rosenthal WS: Acute fatty liver of pregnancy: Complication by disseminated intravascular coagulation. JAMA 231:159–161, 1975

    Google Scholar 

  133. Schultz JC, Adamson JS, Workman WW, Norman TD: Total liver disease after intravenous administration of tetracycline in high doses. N Engl J Med 269:999–1004, 1963

    Google Scholar 

  134. Haemerli UP: Jaundice during pregnancy. New York, Springer-Verlag, 1967, pp 37–39

    Google Scholar 

  135. Schenker S, Breen KJ, Hoyumpa AM: Hepatic encephalopathy: Current status. Gastroenterology 66:121–151, 1974

    Google Scholar 

  136. Whalley PJ, Adams RH, Combes B: Tetracycline toxicity in pregnancy. JAMA 189:357–362, 1964

    Google Scholar 

  137. Combes B, Whalley PJ, Adams RH: Tetracycline and the liver. Progress in Liver Disease, Vol IV. H Popper, F Schaffner (eds). New York, Grune and Stratton 1972

    Google Scholar 

  138. Wruble LD, Ladman AJ, Britt LC, Cummins AJ: Hepatoxicity produced by tetracycline overdosage. JAMA 192:6–8, 1965

    Google Scholar 

  139. Pittman FE, Ainsworth SK, Hennigar GR, Pittman JC: An ultrastructural study of tetracycline hepatotoxicity in man. Gastroenterology 67:821, 1974

    Google Scholar 

  140. Shauer BA, Lukacs L, Zimmerman HJ: Biochemical indices of tetracycline hepatic injury in rats. Proc Soc Biol Geol 147:808–872, 1974

    Google Scholar 

  141. Lewis M, Schenker S, Combes B: Studies on the pathogenesis of tetracycline-induced fatty liver. Am J Dig Dis 12:429–438, 1967

    Google Scholar 

  142. Hansen CH, Pearson LH, Schenker S, Combes B: Impaired secretion of triglycerides by the liver: A cause of tetracycline-induced fatty liver. Proc Soc Exp Biol Med 128:143–146, 1968

    Google Scholar 

  143. Breen KJ, Schenker S, Heimberg M: The effect of tetracycline on the hepatic secretion of triglyceride. Biochem Biophys Acta 270:74–80, 1972

    Google Scholar 

  144. Reye RDK, Morgan G, Baral J: Encephalopathy and fatty degeneration of the viscera: A disease entity in childhood. Lancet 2:749–752, 1963

    Google Scholar 

  145. Schubert WK, Partin JG, Partin JS: Encephalopathy and fatty liver. Progress in Liver Diseases. H Popper, F Schaffner (eds). New York, Grune and Stratton, 1972, p 489

    Google Scholar 

  146. Tang TT, Siegesmund KA, Sedmak GV, Casper JT, Varma RR, McCreadie SR: Reye syndrome. A correlated electron-microscopic, viral and biochemical observation. JAMA 232:1339–1346, 1975

    Google Scholar 

  147. Huttenlocher PR: Reye's syndrome: Relation to outcome of therapy. J Pediatr 80:429–432, 1972

    Google Scholar 

  148. Partin JC, Schubert WK, Partin JS: Mitochondrial ultrastructure in Reye's syndrome. N Engl J Med 285:1339–1342, 1971

    Google Scholar 

  149. Svoboda DJ, Reddy JK: Pathology of the liver in Reye's syndrome. Lab Invest 32:571–579, 1975

    Google Scholar 

  150. Gehlback SH, Wies LA, Sidbury JB Jr: Enzymatic alterations in Reye's syndrome. Pediatrics 55:119–126, 1975

    Google Scholar 

  151. Partin JC, Schubert WK, McLaurin RL, Partin JS: Brain ultrastructure in Reye's syndrome. Clin Res 22:635A, 1974

    Google Scholar 

  152. Cole M, Rutherford RB, Smith FO: Experimental ammonia encephalopathy in the primate. Arch Neurol 26:130–136, 1972

    Google Scholar 

  153. Glick TH, Likosky WH, Levitt LP, Mellin H, Reynolds DW: Reye's syndrome: An epidemiologic approach. Pediatrics 46:371–377, 1970

    Google Scholar 

  154. Linneman CC Jr, Shea L, Kauffman CA, Schiff GM, Partin JC, Schubert WK: Association of Reye's syndrome with viral infection. Lancet 2:179–182, 1974

    Google Scholar 

  155. Firlit CF, Ionasson O, Kahan B, Bergan JJ; Reye's syndrome cadaveric kidneys. Their role in human transplantation. Arch Surg 109:797, 1974

    Google Scholar 

  156. Bressler R, Corredor C, Brendel C: Hypoglycin and hypoglycin-like compounds. Pharmacol Rev 21:105–130, 1969

    Google Scholar 

  157. Olson LC, Bourgeois CH, Cotton RB, Harikul S, Grossman RA, Smith TJ: Encephalopathy and fatty degeneration of the viscera in northeastern Thailand. Clinical syndrome and epidemiology. Pediatrics 47:707–716, 1971

    Google Scholar 

  158. Bourgeois CH, Shank RC, Grossman RA, Johnson DO, Wooding WL, Chandavimol P: Acute aflatoxin B, toxicity in the macaque and its similarities to Reye's syndrome. Lab Invest 24:206–216, 1971

    Google Scholar 

  159. Norman MG: Encephalopathy and fatty degeneration of the viscera in childhood. Can Med Assoc J 99:549–554, 1968

    Google Scholar 

  160. Reynolds DW, Riley HD, LaFont DS, Vorse H, Stout L, Carpenter RL: An outbreak of Reye's syndrome associated with influenza B. J Pediatr 80:429–432, 1972

    Google Scholar 

  161. Curry AS, Guttman HAN, Price DE: Urinary pteridine in a case of liver failure. Lancet 1:885–886, 1962

    Google Scholar 

  162. Cooperstock MS, Tucker RP, Baublis JV: Possible pathogenic role of endotoxin in Reye's syndrome. Lancet I: 1272–1274, 1975

    Google Scholar 

  163. Thaler MM, Hoogenraad NJ, Boswell M: Reye's syndrome due to a novel protein-intolerant variant of ornithine-transcarbamylase deficiency. Lancet 2:438–440, 1974

    Google Scholar 

  164. Thaler MM: Role of ornithine transcarbamylase in Reye's syndrome. N Engl J Med 291:797, 1974

    Google Scholar 

  165. Schubert WK, Bove K Jr, Partin J, Carlson R: Recurrent Reye's syndrome: Case report. Gastroenterology 58:292(A), 1970

    Google Scholar 

  166. DeLong GR, Glick TH, Shannon DC: Citrulline for Reye's syndrome. N Engl J Med 290:1488, 1974

    Google Scholar 

  167. DeLong GR, Snodgrass PJ: Ornithine transcarbamylase deficiency in Reye's syndrome, Proc Reye's Syndrome Conference, Columbus, Ohio, Oct. 1974 (in press)

  168. Brown T, Brown H, Lansky L, Hug G: Carbamyl phosphate synthetase and ornithine transcarbamylase in liver of Reye's syndrome. N Engl J Med 291:797–798, 1974

    Google Scholar 

  169. Kim S, Paik WK, Cohen PP: Ammonia intoxication in rats: Protection byN-Carbymol-L-Glutamate plusL-Arginine. Proc Natl Acad Sci U.S.A. 69:3530–3533, 1972

    Google Scholar 

  170. Bove KE, McAdams AJ, Partin JC, Partin JS, Hug G, Schubert WK: The hepatic lesion in Reye's syndrome. Gastroenterology 69:685–697, 1975

    Google Scholar 

  171. Tremblay GC: Ornithine or citrulline therapy in treatment of Reye's syndrome. N Engl J Med 292:160–161, 1975

    Google Scholar 

  172. Crocker JFS: Insecticide and viral interaction as a cause of fatty visceral changes and encephalopathy in the mouse. Lancet 2:22, 1974

    Google Scholar 

  173. Colon AR, Ledesma BS, Pardo V, Sandberg DH: Viral potentiation of chemical toxins in experimental syndrome of hypoglycemia, encephalopathy and visceral fatty degeneration. Am J Dig Dis 19:1091–1104, 1974

    Google Scholar 

  174. Glasgow AM, Chase HP: Reye's syndrome: A model and hypothesis. Pediatr Res 9:133–138, 1975

    Google Scholar 

  175. Wight PAL, Silver WG, Evans AJ, Bannister DW, Whitehead CC, Blair R: Reye's syndrome of children and the fatty-liver-and kidney syndrome of chickens. Lancet I:1339, 1975

    Google Scholar 

  176. Guillete R, Berlin CM, Finkelstein JD: Reye's syndrome. Clin Proc Child Hosp D.C. 27:224–231, 1971

    Google Scholar 

  177. Silverman A, Roy CC, Cozetto FJ (eds). Pediatric Clinical Gastroenterology St. Louis, Mosby, 1971, p 345

    Google Scholar 

  178. Hilty MD, Romche CA, Delamater PV: Reye's syndrome and hyperammonemia. J Pediatr 84:362–366, 1974

    Google Scholar 

  179. Pross DC, Bradford WD, Kreuger RP: Reye's syndrome treated by peritoneal dialysis. Pediatrics 45:845–847, 1970

    Google Scholar 

  180. Samaha FJ, Blau E, Berardinelli JL: Reye's syndrome—treatment with peritoneal dialysis. Pediatrics 53:336–340, 1974

    Google Scholar 

  181. Nadler H: Therapeutic delirium in Reye's syndrome. Pediatrics 54:265–266, 1974

    Google Scholar 

  182. Partin JS, Partin JC, Schubert WK, McAdams AJ: Liver ultrastructure in abetalipoproteinemia: IA: Evolution of micronodular cirrhosis. Gastroenterology 67:107–118, 1974

    Google Scholar 

  183. Frederickson DS, Gotto AM, Levy RI: Familial lipoprotein deficiency (abetalipoproteinemia, hypobetalipoproteinemia, Tangier disease). The Metabolic Basis of Inherited Disease, 3rd edition. JB Standbury JB Wyngaarden, DS Frederickson (eds). New York, McGraw-Hill, 1972, pp 493–530

    Google Scholar 

  184. Ferraus VJ, Frederickson DS: The pathology of Tangier Disease. Am J Pathol 78:101–158, 1975

    Google Scholar 

  185. Hoffman HN, Donaldson DS: Tangier Disease (familial high density lipoprotein deficiency). Clinical and genetic features in two adults. Am J Med 39:582–593, 1965

    Google Scholar 

  186. Kummer H, Laissue J, Spilss H, Pflugshaupt R, Buchler U: Familiare analphalipoproteinamie (Tangier-Kranheit). Schweiz Med Wsch 98:406–412, 1968

    Google Scholar 

  187. Abramov A, Schorr S, Wolman M: Generalized xanthomatosis with calcified adrenals. Am J Dis Child 91:282–286, 1956

    Google Scholar 

  188. Wolman M, Sterk VV, Gatt S, Frenkel M: Primary familial xanthomatosis with involvement and calcification of the adrenals. Report of two more cases in siblings of a previously described infant. Pediatrics 28:742–757, 1961

    Google Scholar 

  189. Crocker AC, Vawter GF, Neuhauser EBD, Rosowsky A: Wolman's disease: Three new patients with recently described lipidosis. Pediatrics 35:627–640, 1965

    Google Scholar 

  190. Sloan HR, Frederickson DS: Rare familial diseases with neutral lipid storage: Wolman's disease, cholesteryl ester storage disease, and cerebrotindinous xanthomatosis. The Metabolic Basis of Inherited Diseases. 3rd edition. JB Standbury, JB Wyngaarden, DS Frederickson (eds). New York, McGraw-Hill, 1972, pp 808–832

    Google Scholar 

  191. Schiff L, Schubert WK, McAdams AJ, Speigel EL, O'Donnell JF: Hepatic cholesterol disease, a familial disorder. Am J Med 44:538–546, 1968

    Google Scholar 

  192. Schiff L, Schubert WK, Hoyumpa A: Effects of clofibrate in cholesterol ester storage disease. Gastroenterology 56:414, 1969

    Google Scholar 

  193. Volk BW, Wallace BJ: The liver in lipidosis. Am J Pathol 49:203–225, 1966

    Google Scholar 

  194. Bell LS, Blair WC, Lindsay S, Watson SJ: Lesions of galactose diabetes. Arch Pathol 49:393–403, 1950

    Google Scholar 

  195. Donnell GN, Lann SH: Galactosemia. Report of four cases. Pediatrics 7:503–515, 1951

    Google Scholar 

  196. Smetana HF, Olen E: Hereditary galactose disease. Am J Clin Pathol 38:3–25, 1962

    Google Scholar 

  197. Medline A, Medline NM: Galactosemia: Early structural changes in the liver. Can Med Assoc J 107:877–878, 1972

    Google Scholar 

  198. Haworth JC, Coodin FJ: Liver failure in galactosemia successfully treated by exchange blood transfusion. Can Med Assoc J 105:301, 1971

    Google Scholar 

  199. Raju L, Chessells JM, Kemball M: Manifestations of hereditary fructase intolerance. Br Med J I:446–447, 1971

    Google Scholar 

  200. Baker L, Winegard AI: Fasting hypoglycemia and metabolic acidosis associated with deficiency of hepatic fructose-l, 6-diphosphatase activity. Lancet 2:13–16, 1970

    Google Scholar 

  201. Gall EA, Landing BH: Hepatic cirrhosis and hereditary disorders of metabolism. Am J Clin Pathol 26:1398–1426, 1956

    Google Scholar 

  202. Sternlieb I: Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease. Gastroenterology 55:354–367, 1968

    Google Scholar 

  203. Steinberg D: Phytanic acid storage disease: Refsum's syndrome. The Metabolic Basis of Inherited Disease, 3rd edition. JB Stanbury, JB Wyngaarden, DS Frederickson (eds). New York, McGraw-Hill, 1972, pp 833–853

    Google Scholar 

  204. Hutton D, Steinberg D: Localization of the enzymatic defect in phytanic acid storage disease (Refsum's disease). Neurology 23:1333–1334, 1973

    Google Scholar 

  205. Wadlington WB, Riley HD: Familial disease characterized by neonatal jaundice, and probable hepatosteatosis and kernicterus: A new syndrome? Pediatrics 51:192–198, 1973

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Vanderbilt University Medical School and Veterans Administration Hospital, 37203, Nashville, Tennessee

    Anastacio M. Hoyumpa Jr. MD, Harry L. Greene MD, G. Dewey Dunn MD & Steven Schenker MD

Authors
  1. Anastacio M. Hoyumpa Jr. MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harry L. Greene MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Dewey Dunn MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Steven Schenker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Research supported by NIH Grant 5 RO 1 AA 00267-05.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoyumpa, A.M., Greene, H.L., Dunn, G.D. et al. Fatty liver: Biochemical and clinical considerations. Digest Dis Sci 20, 1142–1170 (1975). https://doi.org/10.1007/BF01070758

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01070758

Keywords

Search

Navigation